Brain zapping study halted early: could it have helped heavy drinkers think more flexibly?
NCT ID NCT06634771
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a single session of non-invasive brain stimulation (alpha-tACS) could change brain activity and help people break habits. Researchers compared the stimulation to a fake (sham) version in healthy adults and those with a history of heavy drinking. The study was terminated early and only enrolled 7 people, so no firm conclusions can be drawn.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- transcranial alternating current stimulation (tACS)
- What this could lead to
- If successful, this could point toward a non-invasive way to improve behavioral flexibility, potentially helping people with addiction or impulse control issues.
- What could go wrong
- This was a very small, early-stage study that was terminated before completion. Results may not be reliable or generalizable. The intervention is experimental and not proven to work.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
7 people
The number who actually took part.
- Started
-
Jul 2024
- Finished
-
Jan 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
22 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * • 22-50 years old * Have a high school diploma or equivalent * Medically healthy * Fluent in English For RISK group only: * High risk alcohol use in the past month \[World Health Organization (WHO ) risk level 2-4\] * No history of adolescent binge drinking For RISK+ Adolescent binge alcohol (AIE) group only: * High risk alcohol use in the past month (WHO risk level 2-4) * High levels of adolescent alcohol use (4 or more binge drinking episodes before age 18) For Control (CON) group only: * Low risk alcohol use throughout the lifetime (WHO risk level 0-1) * No history of adolescent binge drinking * No lifetime history of Alcohol Use Disorder (AUD) Exclusion Criteria: * Any individual who meets one or more of the following criteria will be excluded from participation \[excluding positive breath alcohol concentration (BAC), urine drug screen, psychiatric diagnoses, and color blindness, all will be self-reported\]: * Lifetime history of a substance use disorder (SUD; including nicotine) but participants will not be excluded for an AUD. * Neurological disease such as dementia, seizures or head trauma * History of psychosis or psychotic episodes * Diagnosis of attention deficit hyperactivity disorder (ADHD) * Any systemic or inflammatory disease that could affect cognitive functioning (e.g., cancer, cardiovascular disease) * Any motor or visual disturbances that could hinder task performance (e.g., color blindness) * Use of psychoactive recreational drugs in the past month (excluding caffeine and alcohol) * Use of psychotropic medications in the past month including antidepressants, mood stabilizers, antipsychotics, anxiolytics, stimulants, or hypnotics (excluding antidepressant use when dosage has been stable for 1 month or longer) * Use of therapeutic brain stimulation \[e.g. transcranial magnetic stimulation (TMS) or electroconvulsive therapy (ECT)\] in the past month * Any history of brain surgery * History of migraine headaches * Pregnancy * Any brain implants or devices * First degree relative with primary epilepsy * Claustrophobia * Any magnetic resonance imaging (MRI) contraindication based on the University of North Carolina Biomedical Research Imaging Center's MRI safety checklist * Breath alcohol above 0.0% at time of session * Positive urine drug screen at time of session If a participant should have an exclusion criterion arise in the course of their participation (e.g. pregnancy or psychotic episode), their participation in the study will end unless the circumstances are transitory in nature (e.g. positive breath alcohol or urine drug screen).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Behavioral flexibility are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of North Carolina, Chapel Hill
Chapel Hill, North Carolina, 27599, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New sedative candidate goes Head-to-Head with propofol in early human test
- Can a Room-Temperature dairy drink build muscle?
- New injection MWN117 tested for safety in obesity
- Can a new drug avoid the high? soticlestat put to the test
- Liver trouble changes how drugs work: scientists test soticlestat
- Can a hard cycling sprint change a Heart-Calming peptide?